New Jersey Medical School —also known as Rutgers New Jersey Medical School—is a graduate medical school of Rutgers University that has been part of the Rutgers Division of Biomedical and Health Sciences since the 2013 dissolution of the University of Medicine and Dentistry of New Jersey.

During the past decade, New Jersey Medical School Clinical Research Center CRS conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 18 clinical trials were completed, i.e. on average, 78.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Jersey Medical School Clinical Research Center CRS" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 33 trials, followed by "AIDS Clinical Trials Group" with 5 trials sponsored, "University of Minnesota" with 3 trials sponsored, "COVID-19 Prevention Network" with 1 trials sponsored and "HIV Vaccine Trials Network" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Jersey Medical School Clinical Research Center CRS" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 13 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 11 trials as a collaborator, "National Institutes of Health (NIH)" with 4 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator and "ViiV Healthcare" with 3 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "New Jersey Medical School Clinical Research Center CRS" are "HIV Infections" (29 trials), "HIV-1 Infection" (5 trials), "HIV Infection" (3 trials), "Hepatitis B" (3 trials) and "COVID-19" (2 trials). Many other conditions were trialed in "New Jersey Medical School Clinical Research Center CRS" in a lesser frequency.

Most popular intervention types in "New Jersey Medical School Clinical Research Center CRS" are "Drug" (30 trials), "Biological" (11 trials), "Other" (4 trials), "Dietary Supplement" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Darunavir" (2 trials), "Maraviroc" (2 trials), "Nevirapine" (2 trials) and "Pitavastatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "New Jersey Medical School Clinical Research Center CRS" are 37 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "New Jersey Medical School Clinical Research Center CRS". undefined are not yet recruiting, 5 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in New Jersey Medical School Clinical Research Center CRS, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in New Jersey Medical School Clinical Research Center CRS, 5 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".